Japan Contraceptives Drugs Devices Market Insight
Published: 04 July 2026 | Report Format: Electronic (PDF) | Author: Aditi and Govind
The growth rate of the contraceptives drugs and devices market in Japan is expected to grow at a rate of 5.40% owing to increasing awareness regarding reproductive health, rising government focus on family planning initiatives, expanding approvals for advanced oral contraceptive formulations, and growing preference for long-acting reversible contraceptives (LARCs) among the urban female population
Japan Contraceptives Drugs Devices Market Insights Forecasts to 2035
- The Japan Contraceptives Drugs Devices Market Size Was Estimated USD 512.4 Million in 2025
- The Market Size is Expected to Grow at a CAGR of around 5.40% from 2025 to 2035
- The Japan Contraceptives Drugs Devices Market Size is Expected to rise around USD 867.1 Million by 2035
Notable Insights for the Japan Contraceptives Drugs Devices Market
- Based on the Segmentation by Product Type, it can be observed that the Contraceptive Drugs & Oral Pills segment is taking lead in Japan Contraceptives Drugs Devices Market in 2025, holding almost 54% of the total market share due to growing use of emergency contraceptive pills, low-dose daily formulations, and rising prescription access across healthcare retail channels.
- Based on the Segmentation by Application, it can be seen that Hospitals, Gynecology Clinics & Retail Pharmacies segment held a market share of about 61% in Japan Contraceptives Drugs Devices Market in 2025, mainly driven by growing demands for professional medical consultations, specialized reproductive health clinics, and decentralized prescription fulfillment models.
- The global revenue of Fuji Latex Co., Ltd. in fiscal year 2025 stood at nearly $168 Million backed by growing demands for advanced polymer-based protection systems, healthcare rubber-derived medical products, and specialized wellness accessories.
Download the eBook (ToC)
- Increasing investments in AI-based sensing, intelligent digital prescription infrastructure, and smart telemedicine monitoring networks will fuel the growth of the market in coming years, as advanced diagnostic integration enhances treatment compliance precision up to 42% and minimizes clinical diagnostic processing time errors up to 26%.
What Makes Decisions Advisors Research Unique?
Intelligent Market Research Based on AI for Healthcare & Pharmaceuticals
Decisions Advisors offers intelligent market research which includes advanced analysis of therapeutic medication trends, clinical device manufacturing breakthroughs, AI-driven healthcare diagnostics, and targeted market access strategies. Our research identifies potential areas of business development, technology adoption rates, competitive position analysis, and important strategic changes in Japan Contraceptives Drugs Devices Market.
Highly Effective Research Approaches with Accurate Forecast Analysis
The research process uses advanced methodologies such as primary research interview approaches, industry research, tracking the pharmaceutical value chain, and data triangulation to deliver accurate market sizing, CAGR forecasting, investment analysis, and technology forecasting. The study examines the demand for medical and drug solutions in hospital networks, dedicated obstetrics clinics, public wellness campaigns, and e-pharmacy procurement networks in Japan.
Highly Competitive Environment Analysis
In-depth analysis of key pharmaceutical players, innovative medical device design trends, integrated digital health solutions, product launch activities, and strategic global partnerships is included in the report. The report also covers medical device regulations, Ministry of Health, Labour and Welfare (MHLW) policies, manufacturing quality frameworks, and new clinical distribution channel paths in the Japan Contraceptives Drugs Devices Market.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the Japan Contraceptives Drugs Devices Market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Companies in Japan Contraceptives Drugs Devices Market
- Fuji Latex Co., Ltd.
- Okamoto Industries, Inc.
- Bayer Yakuhin, Ltd.
- Mochida Pharmaceutical Co., Ltd.
- Aska Pharmaceutical Co., Ltd.
- Organon Japan KK
- Pfizer Japan Inc.
- Terumo Corporation
- Nipro Corporation
- Sagami Rubber Industries Co., Ltd.
Recent Developments:
- In November 2025, Aska Pharmaceutical Co., Ltd. expanded its therapeutic portfolio by launching a next-generation low-dose oral contraceptive formulation optimized for improved patient compliance and reduced clinical side effects.
- In July 2025, Okamoto Industries, Inc. announced a strategic partnership with regional reproductive wellness organizations to co-develop and distribute advanced ultra-thin protective devices integrated with biocompatible materials.
Market Segmentation:
Japan Contraceptives Drugs Devices Market, By Product Type
- Contraceptive Oral Pills & Drugs
- Intrauterine Devices (IUDs)
- Subdermal Contraceptive Implants
- Condoms & Barrier Protection Devices
- Vaginal Rings & Injectable Contraceptives
Japan Contraceptives Drugs Devices Market, By Distribution Channel
- Hospital Pharmacies
- Gynecology Clinics & Medical Centers
- Retail Pharmacies & Drugstores
- Online E-Commerce & Telehealth Platforms
Japan Contraceptives Drugs Devices Market, By End-User Profile
- Young Adult Consumers
- Family Planning & Spacing Demographics
- Clinical Therapeutics & Hormone Management Cases
Expert Views:
The expansion of the contraceptives drugs and devices market in Japan will be facilitated by rising consumer focus on reproductive autonomy, proactive wellness practices, and the increasing modernization of therapeutic healthcare guidelines. The integration of clinical product designs, seamless digital consultation frameworks, and retail distribution efficiency tools will enhance patient care delivery and drive steady demands across specialized hospitals, regional clinics, and pharmaceutical retail nodes in Japan.
Author: Aditi and Govind By Decisions Advisors and Consulting